Clinical Trial Update: Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a dose-ranging Phase 1/2 trial evaluating topical creams containing API 31510 for superficial basal cell carcinoma, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Basal Cell Carcinoma

Drugs mentioned

• API 31510 topical cream (API 31510)

Snippet

Sponsor: BPGbio | Conditions: Superficial Basal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-05